Last Price
Where today's price sits in its 52-week range
Asiatic Laboratories Limited ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটির অবস্থা তুলনামূলক দুর্বল (আমাদের বিশ্লেষণে 100-এর মধ্যে 13)। কোম্পানিটি লাভ করছে, তবে গত বছরের তুলনায় মুনাফা কিছুটা কমেছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক বেশি। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 0.7%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Risky
Short-term onlyWeak company, but share is running hot
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks pricey right now — costs more than usual for what you get.
P/E Ratio
114.2
Price per ৳1 of yearly earnings
Dividend Yield
0.70%
Annual cash return on the price
P/B Ratio
2.6
Price per ৳1 of net assets
Trading at 114.2 — above its 5-year average of 24.4.
The raw figures behind the verdict — for the curious.
EPS
৳1.24
Earnings per share (latest year)
P/E Ratio
31.2
Price you pay per ৳1 of earnings
Dividend Yield
0.70%
Annual cash return on the price
Reserve & Surplus
৳497 Cr
Company's accumulated savings
Total Loan
৳142 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 4 years.
Earnings Per Share
Profit you earn per share
Profitable per share every year for 4 years.
Yearly Cash Dividend
% of face value
📢 New 10% dividend just declared
Paid a dividend every year for 2 years running.
What the share price has been doing over the last week.
Up 11.1% in the past week, beating the overall market.
Past week
+11.1%
Price move over 7 days
Vs market
+10.3%
Ahead/behind the DSEX index
Trading volume
1.1×
vs its normal volume
Up days
5/7
Green days this week
52-week spot
97%
Position in 1-year range
Trades around ৳14.9 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
Watch-outs
ASIATICLAB scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| ASIATICLAB | 13 | ৳142 | +0.1% | 114.2 | +0.7% | — |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Worth watching — big institutions cut their stake from 18.1% to 16.9% since Jun 2025. Keep an eye on why.
Owners (sponsors) hold 41% — a strong sign of commitment.
Recent news and announcements about this company.